When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MGNX - MacroGenics' margetuximab an Orphan Drug in U.S. for gastric cancer
MacroGenics Inc.
The FDA has granted Orphan Drug Designation to MacroGenics' (NASDAQ:MGNX) margetuximab, an investigational, Fc-engineered monoclonal antibody targeting HER2 for the treatment of gastric and gastroesophageal junction cancer.
More news on: MacroGenics, Inc., Healthcare stocks news,